Taking the tripping out of psychedelic medicine. Magazine Article, 9/28/2022, Nature. https://www.nature.com/articles/d41586-022-02869-4
How Psychedelics Could fix the Brain. Podcast, 9/27/2022, Babbage from the Economist. https://podcasts.apple.com/us/podcast/babbage-how-psychedelics-could-fix-the-brain/id508376907?i=1000580833219
Ketamine, psilocybin and ecstasy are coming to the medicine cabinet, Magazine Article, 9/21/2022, The Economist. https://www.economist.com/technology-quarterly/2022/09/21/ketamine-psilocybin-and-ecstasy-are-coming-to-the-medicine-cabinet
Delix Therapeutics : psychedelics without the trip. Magazine Article, 8/19/2022, Nature Biotechnology. https://www.nature.com/articles/d41587-022-00006-0
The Psychedelics Industry’s Next Hurdle Is How to Go Mainstream. Magazine Article, 7/25/2022, Bloomberg. https://www.bloomberg.com/news/newsletters/2022-07-25/with-magic-mushrooms-legal-in-more-places-psychedelics-face-a-mainstream-debate?sref=9VC1mg1e
Taking the Magic Out of Magic Mushrooms, Newspaper Article, 7/15/2022, New York Times (Cover of the Sunday Review). https://www.nytimes.com/2022/07/15/opinion/hallucinations-psychedelics-depression.html
Changing Minds. Magazine Article, 6/2/2022, UC Davis Magazine. https://magazine.ucdavis.edu/changing-minds/
Wellness: Ketamine. Is Ketamine the Next Big Thing in Psychiatric Therapy? Magazine Article, 4/20/2022, Sacramento Magazine. https://www.sacmag.com/health/wellness-ketamine/
Research on mice that ‘sweat out’ fat wins STAT Madness for University of Pennsylvania. Magazine Article, 4/4/2022, STAT. https://www.statnews.com/2022/04/04/stat-madness-2022-champion-mice-sweat-out-fat-through-skin/
Drug companies are investing big in psychedelics, but can they engineer out the trip? Magazine Article, 3/6/2022, C&E News. https://cen.acs.org/pharmaceuticals/drug-development/Drug-companies-investing-big-psychedelics/100/i9
Relieving depression with LSD-like drugs without causing hallucinations. Magazine Article, 1/31/2022, Fierce Biotech. https://www.fiercebiotech.com/research/relieving-depression-lsd-like-drugs-without-hallucinations
No hallucinations? LSD relatives appear to treat depression in mice, without obvious side effects. Magazine Article, 1/27/2022, Science. https://www.science.org/content/article/no-hallucinations-lsd-relatives-appear-treat-depression-mice-without-obvious-side?utm_campaign=NewsfromScience&utm_source=Social&utm_medium=Twitter
Hallucinogen Chemistry Guides Antidepressant Drug Discovery. Magazine Article, 1/27/2022, C&E News. https://cen.acs.org/pharmaceuticals/drug-discovery/Hallucinogen-chemistry-guides-antidepressant-drug/100/web/2022/01?utm_source=BH&utm_medium=Social&utm_campaign=CEN
The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of. Magazine Article, 1/24/2022, Motherboard. https://www.vice.com/en/article/m7v3dq/the-future-of-psychedelic-medicine-will-be-drugs-youve-never-heard-of
The Promises and Perils of Psychedelic Health Care. Newspaper Article, 1/5/2022, The New York Times. https://www.nytimes.com/2022/01/05/well/psychedelic-drugs-mental-health-therapy.html
Harnessing Psychedelics for Healing. Magazine Article, 12/3/21, Comstock. https://joom.ag/8PmI/p46
Sacramento Region Innovation Awards: Delix Therapeutics explores psychedelics for use in brain therapy. Magazine Article, 11/19/21, Sacramento Business Journal. https://www.bizjournals.com/sacramento/inno/stories/awards/2021/11/19/innovation-awards-delix-therapeutics.html
Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip. Magazine Article, 10/1/21, Forbes. https://www.forbes.com/sites/willyakowicz/2021/10/01/delix-therapeutics-pursues-a-psychedelic-inspired-medicine-without-the-trip/?sh=3a90b4e11030
UC Davis psychedelics startup Delix Therapeutics raises $70 million for clinical trials, Magazine Article, 9/27/21, Sacramento Business Journal. https://www.bizjournals.com/sacramento/news/2021/09/27/delix-therapeutics-raises-70-million.html
Delix raises $70 million to synthesize psychedelic-inspired drugs. Magazine Article, 9/27/21, C&E News. https://cen.acs.org/pharmaceuticals/neuroscience/Delix-raises-70-million-synthesize/99/web/2021/09
A new psychedelics player emerges to treat mental health disorders — minus the hallucinogenic effects. Magazine Article, 9/27/21, Endpoints. https://endpts.com/a-new-psychedelics-player-emerges-to-treat-mental-health-disorders-minus-the-hallucinogenic-effects/
Drug Startup Raises $70 Million for Psychedelics Without a Trip. Magazine Article, 9/27/21, Bloomberg. https://www.bloomberg.com/news/articles/2021-09-27/drug-startup-raises-70-million-for-psychedelics-without-a-trip
Delix raises $70M to test psychedelic analogs for treating brain disorders in clinical trials next year. Magazine Article, 9/27/21, Fierce Biotech. https://www.fiercebiotech.com/biotech/delix-raises-70m-to-test-psychedelic-analogs-for-treating-brain-disorders-clinical-trials
Delix Therapeutics named one of the Fierce 15. Magazine Article, 9/27/21, Fierce Biotech. https://www.fiercebiotech.com/special-report/delix-therapeutics-fierce-biotech-s-2021-fierce-15
Move Over, Psilocybin And Ketamine: A New Compound Derived From A Naturally-Growing Hallucinogen May Revolutionize Psychiatry, Magazine Article, 6/23/2021, Forbes.
Can we take the high out of psychedelics, Magazine Article, 6/3/2021, WIRED UK.
Biosensor Advances Drug Discovery, Magazine Article, 5/11/2021, NIH Research Matters.
How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry, Magazine Article, 5/7/2021, Benzinga.
Sensor sheds light on hallucinogenic activity, Magazine Article, 4/29/2021, C&E News.
Psychedelic drugs without the trip? This sensor could help seek them out, Magazine Article, 4/29/2021, Nature.
Non-hallucinogenic psychedelics: scientists close in on compound, Magazine Article, 4/29/2021, The Guardian.
Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction. Magazine Article, 4/5/2021, Time.
A Safter Psychedelic. Podcast, 1/21/2021, Bio Eats World (Andreessen Horowitz)
Psychedelic derivative dampens addiction, Magazine Article, 12/17/2020, Nature Reviews Drug Discovery.
NPR All Things Considered Radio Interview about Olson Lab Research, Radio Interview, 12/09/2020, NPR.
Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction, Magazine Article, 12/09/2020, NPR.
Ibogaine inspires potential neuropsychiatric treatment, Magazine Article, 12/09/2020, C&E News.
Chemists re-engineer a psychedelic to treat depression and addiction in rodents, Magazine Article, 12/09/2020, Science.
Psychedelics re-engineered for potential use in the clinic, Magazine Article, 12/09/2020, Nature.
Can Psychedelic Drugs Treat Depression, Television Interview, 03/20/2019, Al Jazeera.
A New Chapter in the Science of Psychedelic Microdosing, Magazine Article, 03/05/2019, The Atlantic.
For Babies, Life May Be a Trip, Newspaper Article, 07/18/2018, The Wall Street Journal.
Psychedelics forge connections between neurons, Magazine Article, 06/13/2018, C&E News.
LSD and DMT Caused the Brain to Form New Connections in Flies and Rats, Magazine Article, 06/12/2018, Motherboard.
Psychedelic drugs change brain cells in ways that could help fight depression, addiction and more, Newspaper Article, 06/12/2018, Los Angeles Times.
LSD and magic mushrooms could heal damaged brain cells in people suffering from depression, study shows, Newspaper Article, 06/12/2018, The Independent.
Psychedelic Drugs May Help the Brain Repair Itself, Study Finds, Magazine Article, 06/12/2018, Gizmodo.
